Show
Sort by
-
- Journal Article
- A1
- open access
Targeted AURKA degradation : towards new therapeutic agents for neuroblastoma
-
- Journal Article
- A1
- open access
Molecular mechanisms of nemorosone-induced ferroptosis in cancer cells
-
Overcoming inter-observer planning variability in target volume contouring and dose planning for high-risk neuroblastoma : a European multicenter effort of the SIOPEN Radiotherapy Committee
-
- Journal Article
- A1
- open access
Mitotic dysregulation at tumor initiation creates a therapeutic vulnerability to combination anti-mitotic and pro-apoptotic agents for MYCN-driven neuroblastoma
-
Pinpointing molecular mechanisms of long non-coding RNAs : at the crossroads of biochemistry and genetics
(2022) -
- Journal Article
- A1
- open access
The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples
-
- Journal Article
- A1
- open access
A novel standard for systematic reporting of neuroblastoma surgery : the International Neuroblastoma Surgical Report Form (INSRF), a joint initiative by the Pediatric Oncological Cooperative Groups SIOPEN, COG and GPOH
-
- Journal Article
- A1
- open access
ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation
-
- Journal Article
- A1
- open access
ATR inhibition enables complete tumour regression in ALK-driven NB mouse models
-
- Journal Article
- A1
- open access
A G316A polymorphism in the ornithine decarboxylase gene promoter modulates MYCN-driven childhood neuroblastoma